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Objectives: Dried blood spot (DBS) technology is a microsampling alternative to
traditional plasma or serum sampling for pharmaco- or toxicokinetic evaluation.
DBS technology has been applied to diagnostic screening in drug discovery,
nonclinical, and clinical settings. We have developed an improved elution pro-
tocol involving boiling of blood spots dried on Whatman filter paper.
Methods: The purpose of this study was to compare the quality, purity, and
quantity of DNA isolated from frozen blood samples and DBSs. We optimized a
method for extraction and estimation of DNA from blood spots dried on filter
paper (3-mm FTA card). A single DBS containing 40 mL blood was used.
Results: DNA was efficiently extracted in phosphate-buffered saline (PBS) or Tris-
EDTA (TE) buffer by incubation at 37C overnight. DNA was stable in DBSs that
were stored at room temperature or frozen. The housekeeping genes GAPDH and
beta-actin were used as positive standards for polymerase chain reaction (PCR)
validation of general diagnostic screening.
Conclusion: Our simple and convenient DBS storage and extraction methods are
suitable for diagnostic screening by using very small volumes of blood collected
on filter paper, and can be used in biobanks for blood sample storage.1. Introduction
Biological samples collected in biobanks constitute a
resource with significant research potential, but may also
be subject to various ethical and deontological conflicts.
Moreover, many samples now stored in biobanks were
collected many years earlier, under nonstandardized
conditions and in contexts where awareness of the needted under the terms of the C
0) which permits unrestrict
roperly cited.
ase Control and Preventionto meticulously handle information and obtain consent
was not yet widespread. The problems this presents for
the use of samples has been noted worldwide and has
been addressed in different ways [1].
In 2010, the Italian Joint Group CNB-CNBBSV
(National Committee of BioethicseNational Commit-
tee for Biosecurity Biotechnologies and Life Sciences)
published recommendations for the storage and use ofreative Commons Attribution Non-Commercial License (http://
ed non-commercial use, distribution, and reproduction in any
. Published by Elsevier Korea LLC. All rights reserved.
352 E.-H. Choi, et aldried blood spots (DBSs), and the development of a
national network of regional newborn screening re-
positories for the collection of residual DBSs [2].
Collection of blood samples on filter paper was first
performed >50 years earlier [1]. This simple collection
and storage method has broadly been adopted in diag-
nostic screening [3], drug monitoring [4], and genetic
analysis [5], and is particularly suitable for molecular
epidemiologic studies in remote tropical areas, where
transport and storage conditions are often suboptimal.
The DBSs used in this study were obtained by finger
or heel pricks, and were spotted onto filter paper. The
analysis of human blood dates back to 1963, when Dr
Robert Guthrie used DBS specimens for phenylalanine
analysis to identify newborns with phenylketonuria.
This novel approach to blood collection facilitated
population screening of newborns and other clinical
testing applications [6].
DBSs can easily be collected by a heel or finger prick
without the need for venipuncture; they can be stored at
room temperature and easily transported to the testing
laboratory with little biohazard risk. The use of stored
DBS samples combined with clinical information from
medical registries constitutes an ideal resource for large
population studies of patients under a given age without
selection bias. In addition, DBSs offer several advan-
tages in areas that lack appropriate infrastructure for
processing blood and a cold chain for the transportation
and storage of blood products [7].
Generally, the use of neonatal DBSs is based on the
removal of blood spots using punches, typically 3e6 mm
in diameter, followed by physical or biochemical analysis
of serum analytes released from the punched-out material
by soaking it in alcohol or water [8]. More recently, DBSs
have been used to screen for heritable traits at the DNA
level; typically, they have been used for traits such as
cystic fibrosis, thalassemia, and other traits that are readily
assessed by polymerase chain reaction (PCR).
The use of DBSs has expanded from their modest
beginning in the diagnostic arena for neonatal screening
[3] to drug development, including discovery research
[9,10], nonclinical and clinical toxico- and pharmaco-
kinetic evaluations, and therapeutic drug monitoring
[11e13]. This is due to the multifold advantages of DBS
with respect to scientific, practical, ethical, and cost-
effective aspects in nonclinical and clinical settings
[14e17].
DBSs represent a valuable and comprehensive ge-
netic repository because genomic DNA can be isolated
from blood samples processed on these filter papers for
use in PCR [18]. In addition, direct PCR amplification
from DBSs that have been punched out has been re-
ported [19].
We analyzed whole blood and buffy coats in com-
parison with DBSs, in terms of storage temperature,
buffer stability, and DNA yield. We have presented a
storage and extraction method for DBSs on filter paper,with PCR verification. We have developed a reliable
system for good blood storage practice, blood sample
preparation and processing, conditions, and acceptance
criteria for DBS applications.2. Materials and methods
2.1. Collection and storage of blood specimens
Blood samples were collected in EDTA tubes from
unaffected individuals tested at the Eulji University
Hospital, Daejeon, Korea. All blood samples were ob-
tained from young adults (20e40 years) as whole blood
in EDTA and as DBS samples.
DBS samples (40 mL each) were spotted on Whatman
FTA cards (Whatman Inc., Brentford, UK) and were
dried for 24 hours at room temperature. They were
stored at room temperature or at 80C until analysis,
and then kept in separate clean zipper bags for 2, 4
weeks and 3 months. Liquid, EDTA-treated blood
samples were also stored at 80C for 2, 4 weeks and 3
months.
2.2. DNA extraction from DBSs
For single-stranded DNA (ssDNA) extraction, DBSs
on the cards were cut into small pieces with scissors and
transferred into 1.5-mL microtubes to which 500 mL
dH2O had been added; the tubes were kept at room
temperature for 5 minutes. The dH2O was discarded,
and the procedure was repeated twice. The filter papers
were soaked in 500 mL extraction buffer [phosphate-
buffered saline (PBS) or 10 mM Tris-EDTA (TE)].
For lysis, red blood cell lysis buffer (100 mL) was
added to the filter papers, which were then incubated
with 10 mL (1 mg/mL) proteinase K at 37C overnight.
After blood cell lysis, the filter papers were pressed
against the bottom of the tube several times with a clean
pipette tip [20]. For increased extraction efficiency, cell
lysates were incubated at 95C for 15 minutes. Filter
papers were removed after brief centrifugation (2e3
seconds), and the DNA-containing supernatant was
stored at 80C until analysis.
For double-stranded DNA (dsDNA) extraction, each
filter paper sample that had been punched out was
soaked in 40 mL Tris-EDTA buffer or PBS, and incu-
bated at 37C overnight. Genomic DNA was isolated
from blood using the DNeasy Blood and Tissue kit
(Qiagen, Valencia, CA, USA) as per the manufacturer’s
instructions.
2.3. DNA concentration
DNA concentrations were determined by measuring
absorbance at 260 nm (A260), and assuming that an A260
of 1.0 is equal to 50 ng/mL pure dsDNA or 35 ng/mL
pure ssDNA. Concentrations of extracted DNA were
measured using a SmartSpec plus spectrophotometer
(Bio-Rad, Hercules, CA, USA).
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The levels of the GAPDH and b-actin transcripts
were used to verify the quality of the extracted DNA.
For GAPDH PCR, the PCR reaction mixture contained
3 mL extracted DNA, 10 pmol of each primer, and
Bioneer PCR premix in a final volume of 20 mL.
Thermal cycling was conducted in a CFX96 Touch
system (Bio-Rad), with the following PCR program for
GAPDH: initial denaturation of 8 minutes at 94C;
followed by 40 cycles of 94C for 1 minute, 65C for 1
minute, and 72C for 1 minute; concluding with 7 mi-
nutes at 72C and 1 minute at 4C. A similar PCR
program was used for b-actin PCR, except that the
annealing temperature was 64C. The primer sequences
for GAPDH and b-actin are shown in Table 1 [21].
The PCR products were analyzed by electrophoresis
on 2% RedSafe (Koma)-stained agarose gels in Tris-
acetate-EDTA (TAE) buffer. After electrophoresis, the
digital images were analyzed with a ChemiDoc MP
imaging system (Bio-Rad).3. Results
3.1. Quantitation of DNA from filter paper and
frozen-liquid samples
The recovery ratio of dsDNA was measured as
described in the “Materials and Methods” section. The
dsDNA extracted from DBSs and liquid samples was
stored at room temperature or 80C for 3 months
(Figure 1).
As shown in Figure 2, the recovery ratios of frozen-
liquid and filter paper samples were compared. The
dsDNA was reduced by approximately 68% in the
whole blood and 40% in the buffy coat. The amount of
DNA extracted from the frozen whole blood was
approximately 39% higher than that extracted from the
frozen buffy coat. The amount of DNA extracted from
whole blood kept on filter paper at room temperature
was approximately 11% higher than the yield from the
buffy coat. The stability of DNA in samples collected on
filter paper was higher than that for frozen-liquid sam-
ples. Furthermore, in a comparison of samples stored in
the same manner, the quantity of DNA extracted from
whole-blood samples was approximately 39% higher
than the yield from buffy-coat samples stored frozen and
approximately 11% higher than that from samples stored
on filter paper at room temperature.Table 1. PCR primers (synthesized by GeneWorks, Adelaide, S
Gene
Primers (5
Forward
GAPDH TGA AGG TCG GAG TCA ACG GAT TTG GT
b-actin GCA CCA CAC CTT CTA CAA TG
PCR Z polymerase chain reaction.The ssDNA yields were measured following the
procedure described in Figure 1. We determined that
two storage methods were significantly higher extraction
method of ssDNA quantity. The amount of ssDNA
extracted from samples stored for 2 weeks was similar to
that from samples stored for 4 weeks (Figure 3).
The amount of DNA extracted from DBSs was >62%
and 60% of that obtained from frozen-liquid samples
(whole blood and buffy coats, respectively). The amounts
of DNA extracted from frozen-liquid samples and filter
paper samples at 2 weeks did not differ much from those
extracted at 4 weeks; however, the yield from frozen-
liquid samples was approximately 62% lower than that
from filter paper samples after 2 weeks and approximately
60% lower after 4 weeks. The stability and yield of frozen-
liquid samples were associated with storage temperature.
DNA from DBSs stored at room temperature was of
lower purity than that obtained from frozen-liquid samples
because of impurities in the paper; however, the improved
yield of the extracted ssDNA suggested greater stability
than that obtained in the case of frozen-liquid samples.
3.2. Quantitation of ssDNA from DBS
Tomeasure the DNA yields from samples stored under
different conditions, samples were separated into whole-
blood and buffy-coat samples, spotted on filter papers, and
stored at room temperature; subsequently, the extracted
ssDNA yields were compared (Figure 4). The amount of
ssDNA extracted from buffy-coat samples was approxi-
mately 65% higher than that extracted from whole-blood
samples after 2 weeks and approximately 44% higher
after 4 weeks. Moreover, the purity of ssDNA extracted
from buffy-coat samples was higher than that extracted
from whole-blood samples (data not shown).
Buffy-coat sample yields were approximately three
times higher than whole-blood sample yields after 2
weeks and approximately 2.4 times higher after 4
weeks; however, the difference decreased as the storage
period increased. In the case of whole blood, there was
little difference in ssDNA yield over time. However, the
extraction yield from buffy coats decreased by approx-
imately 20% after 2e4 weeks.
3.3. Yield of ssDNA from DBS at different
storage temperatures and times
As the filter paper storage method provides higher
ssDNA yields than the frozen-liquid method at room
temperature, we investigated how the storageA, Australia).
0e30)
Product
size (bp)Reverse
CAT GTG GGC CAT GAG GTC CAC CAC 983
TGC TTG CTG ATC CAC ATC TG 838
Figure 1. Workflow diagram. dsDNA Z double-stranded DNA; RBC Z red blood cell; ssDNA Z single-stranded DNA.
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ssDNA yields were compared between filter paper
storage temperatures and times; there was little differ-
ence between the amounts of ssDNA extracted. How-
ever, there was a difference of 8% in the ssDNA yields
between 2- and 4-week storage, while there was a 1%
difference in ssDNA yields from samples stored at room
temperature for the same period. Therefore, storage at
room temperature was best for samples on filter paper.Figure 2. DNA recovery from whole blood and Whatman
FTA cards. BC Z buffy coat in dried blood spots stored at
room temperature; dsDNA Z double-stranded DNA;
WB Z whole blood in dried blood spots stored at room
temperature.3.4. Quantitation of ssDNA extracted from
DBSs with different buffers
Extraction yields with PBS and TE buffers were
compared (Figure 6). Neither buffer produced much
difference in yields for different sample storage times;
however, the ssDNA yield in TE buffer was approxi-
mately 5% higher than that in PBS buffer. Therefore, TE
buffer was more suitable than PBS for optimal ssDNA
yield.2 wk 4 wk
Figure 3. Average DNA yield over time. In the figure, fluid
represents whole blood stored at 80C and paper represents
Whatman FTA cards stored at room temperature.
ssDNA Z single-stranded DNA.
Figure 4. DNA extracted by boiling dried blood spots on
filter paper after incubation at 56C. BCZ buffy coat in dried
blood spots stored at room temperature; ssDNA Z single-
stranded DNA; WBZ whole blood in dried blood spots stored
at room temperature.
Figure 5. Yield of ssDNA from dried blood spots stored at
80C and room temperature. ssDNA Z single-stranded
DNA.
Figure 6. Efficiency of ssDNA extraction in PBS and TE.
PBS Z phosphate-buffered saline; ssDNA Z single-stranded
DNA.
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To examine whether the extracted ssDNA could be
used for PCR in medical and scientific research, we
amplified GAPDH and b-actin from dsDNA or ssDNA
extracted from frozen-liquid and filter paper samples.
Nonquantitative PCR amplification of GAPDH and b-
actin DNA was performed with (1) ssDNA from frozen-
liquid samples, (2) dsDNA from filter paper, and (3)
ssDNA from filter paper (Figure 7). The results showed
that the DNA obtained from DBS extraction was of suf-
ficient quality to be used for PCR analysis and that the
yield was better than that obtained from frozen samples.4. Discussion
Compared with conventional plasma sampling, DBS
requires much smaller blood volumes and simpler
storage and transportation conditions, which makes it a
very promising alternative sample-collection proce-
dure. DBS sample preparation requires extraction of
dried blood samples into a solution. This is a step
unique to DBSs for large-molecule sample analysis and
is crucial to the success of the method. For a given
analyte, poor extraction recovery or poor correlation
between the serum/plasma and DBS samples may
indicate that further development of the method is
necessary or that the analyte may not be a good
candidate for the DBS method [22]. Therefore, sample-
extraction conditions and recovery should be evaluated
during method development and confirmed during
method validation.
DBS sampling is most commonly used in clinical
laboratories to assess small-molecule analytes during
screening of newborns for metabolic disorders [2].Figure 7. PCR amplification of GAPDH and b-actin DNA.
DNA was extracted from frozen-liquid samples and dried
blood spots. Lanes 1e2 show dsDNA isolated from frozen
whole blood and the buffy coat; lanes 3e4, dsDNA isolated
from DBSs, with whole blood stored at room temperature; and
lanes 5e6, ssDNA isolated from DBSs, with whole blood and
the buffy coat stored at room temperature and extracted with
the boiling method. BC Z buffy coat in dried blood spots
stored at room temperature; DBS Z dried blood spot;
dsDNA Z double-stranded DNA; PCR Z polymerase chain
reaction; ssDNAZ single-stranded DNA; WBZ whole blood
in dried blood spots stored at room temperature.
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directly onto the DBS collection card; only a portion of
the DBS is removed for analysis. Ideally, the volume of
blood transferred for the assay is defined by the diameter
of the punch and, therefore, does not require precise
measurement of the volume of blood that is spotted.
However, there are several sources of variation unique
to bloodspot sampling. For example, proper placement
of the whole-blood sample on the filter paper is critical,
and errors can be introduced if blood is blotted or
smeared rather than drawn onto the filter paper by
capillary action 16. We minimized this source of error
by rigorous training of the personnel for the procedure
and punching out of the entire blood spot. We focused
on increasing the DNA extraction yield from blood
specimens and maintaining high structural stability of
DNA to retain the most information, with the intent of
securing high-quality human specimens for future
medical and scientific research. We established a
method to obtain high-quality DNA for research by
analyzing dsDNA and ssDNA yields after varying the
storage method, temperature, and elution buffer, all of
which influence DNA extraction.
The importance of DNA recovery from Guthrie
cards has been discussed at length in a recent
comparative study by Sjo¨holm and colleagues [24].
They compared a number of commercially available
kits and procedures for DNA recovery from Guthrie
cards and demonstrated that only approximately
15e25% of the total DNA complement can be recov-
ered. They measured DNA recovery from DBSs stored
for up to 26 years and showed that standard 3-mm
punches provide DNA yields (with the best available
technology) of only approximately 30 ng per punch.
However, they demonstrated that, in spite of the rela-
tively low yields, the small amount of DNA obtained
remains an excellent substrate for whole genome
amplification and relatively complex multiplex single
nucleotide polymorphism (SNP) analysis [24].
In the current study, a comparison of frozen-liquid
storage and DBSs showed that the quantity of dsDNA
extracted using DNA preparation kits was higher
after storage as frozen liquid. The mean dsDNA con-
centration from frozen-liquid samples was 87 ng/mL,
with a standard deviation of 9.6 ng/mL. However, the
mean dsDNA concentration obtained from the DBS
samples was 23 ng/mL, with a standard deviation of
1.7 ng/mL.
When economics are considered, the frozen-liquid
method is limited by manpower and capital re-
quirements. In this regard, DBSs stored at room tem-
perature provide many economic benefits such as
reduced cost and space requirements. However,
genome-scale microarray analysis continues to require
an input DNA concentration (250 ng) that is approxi-
mately 100 times greater than that required for simple
PCR; the DNA must be double stranded and mustcontain intact molecules approximately five times longer
than those required for most PCR reactions.
Therefore, we tried to extract a large amount of
DNA by optimization of an ssDNA extraction method
for a customized DNA resource that can be used for
PCR, which is widely used in DNA research. Extrac-
tion was performed after converting dsDNA to ssDNA
by boiling the filter paper sample at 95C, thereby
releasing a large amount of DNA into the buffer. The
mean ssDNA concentration obtained from the DBS
samples was 24.5 mg/mL, with a standard deviation of
0.54 mg/mL.
Similar results were obtained by Mas et al [23] in a
study on DBSs stored on treated filter paper matrices
such as Whatman FTA or IsoCode, wherein extraction
was performed according to the manufacturer’s in-
structions. In that study, approximately 25% recovery
was obtained in a single extraction, yielding up to
150 ng of ssDNA in 200 mL solution, per 40 mL adult
human blood input.
The general recommendation is DBS sample storage
at 20C to prevent DNA degradation [24]. We
compared DBS storage at room temperature versus that
at 80C. As shown in Figure 5, the concentration of
ssDNA from DBS stored at 80C was similar to the
yield from DBS stored at room temperature, suggesting
that our modified extraction method can be used for
extraction of ssDNA from DBSs stored at room
temperature.
The ssDNA products were compared with dsDNA
products for use in common PCR experiments
(Figure 7). GAPDH and b-actin, human housekeeping
genes, were collinearly expressed in the DBSs and
frozen samples. Thus, DBSs may not be used in
microarray technology, but may be used to analyze the
quantity and quality of ssDNA.
In this study, we analyzed the concentration of DNA
extracted from DBS samples and frozen-liquid samples
from the same healthy adults using a modified DNA
extraction procedure and a commercial kit. The com-
parison revealed a slight advantage of the frozen-liquid
samples over DBS samples with respect to dsDNA
quantity, but the concentration of ssDNA was signifi-
cantly greater in the DBS samples.
The advantages of sampling and storing blood on
filter paper for genetic analyses of human pathogens
highlight the need for reliable, sensitive, and cost-
effective DNA extraction methods. The denaturation-
based DNA extraction method described in this report
has shown superior results in comparison to standard
methods and commercial kits for the extraction of
archived blood samples. Our method is rapid, simple,
and inexpensive, and confers a reduced risk of cross-
contamination due to minimal sample manipulation.
Using our DNA extraction method, archival DBS sam-
ples can provide sufficient DNA for clinical studies and
biobanking.
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